AI assistant
EXELIXIS, INC. — Director's Dealing 2024
Feb 28, 2024
30561_dirs_2024-02-27_b9abf3ee-b223-4eb3-86c7-45f74e8b59d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2024-02-23
Reporting Person: Peterson Amy C. (EVP Prod Dev & Med Aff & CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-23 | Common Stock | A | 82121 | — | Acquired | 322121 | Direct |
Footnotes
F1: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.
F2: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2025 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested.
F3: Includes 322,121 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.